Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function
HMS-03
2 other identifiers
interventional
43
1 country
4
Brief Summary
In this study, the effects of dietary intake of cold-pressed turnip rapeseed oil (CTPRO) and milk fat are compared in men with metabolic syndrome having already participated in HMS-02 study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2004
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 6, 2010
CompletedFirst Posted
Study publicly available on registry
May 7, 2010
CompletedMay 7, 2010
May 1, 2010
7 months
May 6, 2010
May 6, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Circulating lipids
At the end of both 6- to 8-week dietary periods, fasting values of circulating lipids including oxidized LDL are determined
6 to 8 weeks
Platelet function
At the end of both 6- to 8-week dietary periods, platelet function is determined
6 to 8 weeks
Glucose tolerance
During a 5-hour oral glucose-fat tolerance test the area under curve of plasma glucose and insulin concentration is determined
5 hours
Secondary Outcomes (3)
Arterial elasticity
6 to 8 weeks
Serum triglyceride AUC
5 hours
Platelet function
5 hours
Study Arms (2)
Rapeseed oil
ACTIVE COMPARATORMilk fat
ACTIVE COMPARATORInterventions
1. In the dietary period of 6 to 8 weeks: CTPRO 37 ml/day. 2. In the 5-hour oral glucose and fat tolerance test: glucose and CTPRO.
1. In dietary period of 6 to 8 weeks: 37.5 grams of butter. 2. In the 5-hour oral glucose and fat tolerance test: glucose and cream
Eligibility Criteria
You may qualify if:
- men with metabolic syndrome having already participated in the HMS-02 Study
- Willing to participate in a demanding dietary study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kanta-Häme Central Hospitallead
- Linnan Klinikka Oycollaborator
- MTT Agrifood Research Finlandcollaborator
- Finnish Red Cross Blood Servicecollaborator
Study Sites (4)
Linnan Klinikka
Hämeenlinna, 13100, Finland
Central Hospital of Kanta-Häme
Hämeenlinna, 13530, Finland
Finnish Red Cross Blood Transfusion Service
Helsinki, 00310, Finland
MTT Agrifood Research Finland
Jokioinen, 31600, Finland
Related Publications (3)
Saarinen HJ, Husgafvel S, Pohjantahti-Maaroos H, Wallenius M, Palomaki A. Improved insulin sensitivity and lower postprandial triglyceride concentrations after cold-pressed turnip rapeseed oil compared to cream in patients with metabolic syndrome. Diabetol Metab Syndr. 2018 May 4;10:38. doi: 10.1186/s13098-018-0340-7. eCollection 2018.
PMID: 29755591DERIVEDSaarinen HJ, Sittiwet C, Simonen P, Nissinen MJ, Stenman UH, Gylling H, Palomaki A. Determining the mechanisms of dietary turnip rapeseed oil on cholesterol metabolism in men with metabolic syndrome. J Investig Med. 2018 Jan;66(1):11-16. doi: 10.1136/jim-2017-000495. Epub 2017 Aug 11.
PMID: 28801309DERIVEDPalomaki A, Pohjantahti-Maaroos H, Wallenius M, Kankkunen P, Aro H, Husgafvel S, Pihlava JM, Oksanen K. Effects of dietary cold-pressed turnip rapeseed oil and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome. Lipids Health Dis. 2010 Dec 1;9:137. doi: 10.1186/1476-511X-9-137.
PMID: 21122147DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ari K Palomäki, MD PhD
Central Hospital of Kanta-Häme
- STUDY DIRECTOR
Kalevi Oksanen, MD PhD
Central Hospital of Kanta-Häme
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 6, 2010
First Posted
May 7, 2010
Study Start
September 1, 2004
Primary Completion
April 1, 2005
Study Completion
June 1, 2008
Last Updated
May 7, 2010
Record last verified: 2010-05